TAS-4464

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameTAS-4464
Drug Alias NameTAS-4464
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNEDD8 activating enzyme inhibitors
TargetsNEDD8 activating enzyme
Therapy Area/IndicationsMultiple MyelomaLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTaiho Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTaiho Oncology Inc
Active IndicationsN/A
Inactive IndicationsMultiple MyelomaLymphoma, Non-Hodgkin

Other Information

ATC CodeN/A
Related LinksN/A